- Recent Funding
- Investors
- 3L Capital
33L Capital portfolio
3L Capital has 1 portfolio company on record at Recent Funding.
About this page
It is a growth equity firm based in New York, US, founded in 2017. Its most recent investment on record is AvantStay's $20M Series A round in September 2019, which it led, alongside Convivialite Ventures, Bullpen Capital, Zeno Partners and 2 others. That company is in Health and bio.
About 3L Capital
What 3L Capital invests in
- Health and bio · 1 · 100%
- Logistics and mobility · 1 · 100%
- Consumer and social · 1 · 100%
How 3L Capital invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series A | 1 100% | $20M |
3L Capital portfolio companies
AAvantStay$20MSeries A · Sep 2019
| Company | Round with 3L Capital | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series A · $20M · lead | $185M | Jul 13, 2026 Series B+ |
Most frequent co-investors
FF-Prime Capital1 shared round · last Sep 1, 2019
CConvivialite Ventures1 shared round · last Sep 1, 2019
BBullpen Capital1 shared round · last Sep 1, 2019
SShaun White1 shared round · last Sep 1, 2019
ZZeno Partners1 shared round · last Sep 1, 2019
Similar investors
LLTS Growth1 company · 1 deal in 12 mo
FFirst In3 companies · 4 deals in 12 mo
TTidemark4 companies
DDream Ventures6 companies · 3 deals in 12 mo
66 Degrees Capital7 companies · 6 deals in 12 mo
MMYSC7 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.
Share is of the 1 round on Recent Funding that name 3L Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists 3L Capital, which is a subset of its real portfolio. API: /api/v1/investors/3l-capital (get a free API key). More: the most active VC firms and new venture capital funds.